May 2026

Cosibelimab for Advanced Cutaneous Squamous Cell Carcinoma

Pembrolizumab Therapy in Stage III and IV Melanoma

Malassezia Folliculitis: Presentation, Diagnosis, Treatment

Topical Metformin vs Kligman Formula in Melasma

Metformin in Skin Cancer: Mechanistic and Clinical Insights

Weight Loss and Its Impact on Soft Tissue

May 2026 Supplement 1

Mechanism Matters: Il-17  Receptor Blockade with Brodalumab and Its Role in Durable Psoriasis Clearance  and Fast Onset of Action

April 2026

SPECIAL TOPIC: IMMUNODERMATOLOGY

• Remibrutinib Mechanism of Action Dermatologic Conditions
• Racial and Ethnic Representation Janus Kinase Inhibitors
• Isotretinoin Risk Inflammatory Bowel Disease TriNetX
• Eruptive Lentiginosis Within Resolved Psoriasis Plaques
• Diagnostic Accuracy and Pitfalls of Artificial Intelligence Models
• Treatment of Dystrophic Epidermolysis Bullosa With Abrocitinib

April 2026 Supplement 1

Real-World Cases of a Novel Topical Tranexamic Acid Aerum in Treatment of Hyperpigmentation

April 2026 Supplement 2

2025 Poster Abstracts Supplement

March 2026

• Brodalumab’s 8-Year Efficacy and Safety
• Advanced Topical Nonsteroidal Therapies for Atopic Dermatitis
• Efficacy and Safety of Janus Kinase Inhibitors
• Updates on Therapeutic Approaches for Androgenetic Alopecia
• Reversal of Alopecia Totalis Utilizing Dupilumab
• Hair Prosthetic Injuries in Emergency Department Cases
• Topical Ruxolitinib Therapy and Depression Rates

February 2026 Supplement 1

PRE-, INTRA-, AND POSTPROCEDURE SKINCARE

February 2026

• Practical Algorithm for Acne Treatment
• Efficacy and Safety of Clascoterone Cream
• ChatGPT and DeepSeek in Dermatologic Practice
• Efficacy Treatment of Periorbital Hyperpigmentation
• GLP-1 Agonists in Hidradenitis Suppurativa
• Reddit Discourse on Eczema Misinformation

February 2026 Supplement 1

A NOVEL ORAL TREATMENT FOR PSORIASIS: DEUCRAVACITINIB

January 2026

• Cutaneous Adverse Events With GLP-1 Agonists
• Regulatory Landscape of Regenerative Dermatology Frameworks
• Malassezin Compared With Hydroquinone for Melasma
• Novel Topical Agent for Hyperpigmentation Management
• Advanced Multimodal Skin Tone Correcting Serum
• Thiamidol Regimen Compared With SPF Alone

January 2026 Supplement 1

Advancing Care for Thinning Skin: Clinical Evidence and Scientific Insights in Dermatoporosis

December 2025

• Pyoderma Gangrenosum Following Total Colectomy
• Report From the IDEOM Annual Meeting
• GLP-1 Receptor Agonists in HS
• Tirzepatide for Moderate to Severe Hidradenitis Suppurativa
• Atherosclerotic Cardiovascular Disease in Inflammatory Skin Disease
• Clinical Evaluation of Thiamidol Formulations for Hyperpigmentation

December 2025 Supplement

Nordic European Cutaneous Oncodermatology Management (Necom) 7: Real-World Cases Applying Recommendations for the Prevention and Treatment of Skin Reactions Related  to Cancer Therapies Using Skin-Protective Measures